To send content items to your account,
please confirm that you agree to abide by our usage policies.
If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account.
Find out more about sending content to .
To send content items to your Kindle, first ensure email@example.com
is added to your Approved Personal Document E-mail List under your Personal Document Settings
on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part
of your Kindle email address below.
Find out more about sending to your Kindle.
Note you can select to send to either the @free.kindle.com or @kindle.com variations.
‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi.
‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.
Preliminary studies, as well as the authors' own experience over a number of years, suggest a favorable role for immunotherapy using intravenous immunoglobulin (IVIG) and Humira in improving the success rate of in vitro fertilization (IVF) treatment in women suffering from recurrent implantation failure. IVIG down regulates in vivo and in vitro natural killer (NK) cell activity and modifies NK cell cytokine production profile. Compared to the literature on the application of IVIG in recurrent implantation failure patients, studies evaluating the use of the tumour necrosis factor-α (TNF-α) blocker Humira are scarce. The optimum method to prove the efficacy of therapeutic interventions is through conducting adequately powered and well-designed randomized controlled trials. Although the safety profile of immunotherapy has been demonstrated in several uncontrolled studies, further and larger studies including cost-effectiveness evaluation of the proposed interventions will need to be carried out.
Email your librarian or administrator to recommend adding this to your organisation's collection.